Guangdong VTR Bio-Tech Co Ltd (300381) - Total Assets

Latest as of March 2026: CN¥2.88 Billion CNY ≈ $421.34 Million USD

Based on the latest financial reports, Guangdong VTR Bio-Tech Co Ltd (300381) holds total assets worth CN¥2.88 Billion CNY (≈ $421.34 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check 300381 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Guangdong VTR Bio-Tech Co Ltd - Total Assets Trend (2007–2025)

This chart illustrates how Guangdong VTR Bio-Tech Co Ltd's total assets have evolved over time, based on quarterly financial data. Explore 300381 long-term investments to assets to see how much of total assets are deployed in long-term investments.

Guangdong VTR Bio-Tech Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2025)

Guangdong VTR Bio-Tech Co Ltd's total assets of CN¥2.88 Billion consist of 37.9% current assets and 62.1% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	14.2%
Accounts Receivable	CN¥199.34 Million	6.8%
Inventory	CN¥206.55 Million	7.1%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥332.77 Million	11.4%
Goodwill	CN¥36.67 Million	1.3%

Asset Composition Trend (2007–2025)

This chart illustrates how Guangdong VTR Bio-Tech Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Guangdong VTR Bio-Tech Co Ltd market cap and net worth.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Guangdong VTR Bio-Tech Co Ltd's current assets represent 37.9% of total assets in 2025, a decrease from 55.7% in 2007.
Cash Position: Cash and equivalents constituted 14.2% of total assets in 2025, up from 13.8% in 2007.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 12.0% of total assets, an increase from 5.0% in 2007.
Asset Diversification: The largest asset category is intangible assets at 11.4% of total assets.

Guangdong VTR Bio-Tech Co Ltd Competitors by Total Assets

Key competitors of Guangdong VTR Bio-Tech Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Ascendis Pharma AS NASDAQ:ASND	USA	$2.01 Billion
Biomarin Pharmaceutical Inc NASDAQ:BMRN	USA	$8.59 Billion
Spyre Therapeutics Inc. NASDAQ:SYRE	USA	$763.95 Million
3SBio Inc F:83B	Germany	€36.25 Billion
Soleno Therapeutics Inc NASDAQ:SLNO	USA	$608.39 Million
Jiangxi Fushine Pharmaceutical Co Ltd SHE:300497	China	CN¥4.48 Billion
Novavax Inc NASDAQ:NVAX	USA	$1.04 Billion
BB Biotech AG SW:BION	Switzerland	CHF2.64 Billion

Guangdong VTR Bio-Tech Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	4.91	6.89	2.00
Quick Ratio	3.85	5.77	0.96
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥841.74 Million	CN¥1.05 Billion	CN¥990.38 Million

Guangdong VTR Bio-Tech Co Ltd - Advanced Valuation Insights

This section examines the relationship between Guangdong VTR Bio-Tech Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.41
Latest Market Cap to Assets Ratio	0.14
Asset Growth Rate (YoY)	-0.8%
Total Assets	CN¥2.92 Billion
Market Capitalization	$423.24 Million USD

Valuation Analysis

Below Book Valuation: The market values Guangdong VTR Bio-Tech Co Ltd's assets below their book value (0.14x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Guangdong VTR Bio-Tech Co Ltd's assets decreased by 0.8% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Guangdong VTR Bio-Tech Co Ltd (2007–2025)

The table below shows the annual total assets of Guangdong VTR Bio-Tech Co Ltd from 2007 to 2025.

Year	Total Assets	Change
2025-12-31	CN¥2.92 Billion ≈ $428.01 Million	-0.80%
2024-12-31	CN¥2.95 Billion ≈ $431.47 Million	-4.73%
2023-12-31	CN¥3.09 Billion ≈ $452.89 Million	-2.43%
2022-12-31	CN¥3.17 Billion ≈ $464.18 Million	-29.19%
2021-12-31	CN¥4.48 Billion ≈ $655.56 Million	-4.12%
2020-12-31	CN¥4.67 Billion ≈ $683.69 Million	+3.41%
2019-12-31	CN¥4.52 Billion ≈ $661.14 Million	-5.90%
2018-12-31	CN¥4.80 Billion ≈ $702.55 Million	+24.86%
2017-12-31	CN¥3.85 Billion ≈ $562.68 Million	+19.80%
2016-12-31	CN¥3.21 Billion ≈ $469.70 Million	+30.89%
2015-12-31	CN¥2.45 Billion ≈ $358.84 Million	+154.55%
2014-12-31	CN¥963.36 Million ≈ $140.97 Million	+156.12%
2013-12-31	CN¥376.14 Million ≈ $55.04 Million	+26.92%
2012-12-31	CN¥296.37 Million ≈ $43.37 Million	+14.31%
2011-12-31	CN¥259.27 Million ≈ $37.94 Million	+13.33%
2010-12-31	CN¥228.77 Million ≈ $33.48 Million	+17.38%
2009-12-31	CN¥194.90 Million ≈ $28.52 Million	+14.07%
2008-12-31	CN¥170.86 Million ≈ $25.00 Million	+37.84%
2007-12-31	CN¥123.95 Million ≈ $18.14 Million	--

About Guangdong VTR Bio-Tech Co Ltd

SHE:300381 China Biotechnology

Market Cap

$423.24 Million

CN¥2.89 Billion CNY

Market Cap Rank

#13265 Global

#3972 in China

Share Price

CN¥5.89

Change (1 day)

+1.90%

52-Week Range

CN¥5.75 - CN¥7.99

All Time High

CN¥34.00